TCL Archive NCI Staff Recommends Moving Cooperative Groups Into DCT, Increase Funding, Switch Emphasis July 4, 1975
TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
TCL Archive Congress to hold hearings on NIH ethics, Zerhouni pledges greater transparency. January 9, 2004
